Five Prime Therapeutics Announces Third Quarter 2014 Financial Results
November 10, 2014Five Prime Therapeutics provides a corporate update including their drugs in the pipeline, collaborations, and appointed leadership, as well as a summary of financial results and guidance for Q3 ending September 30, 2014.
More »
Atara Biotherapeutics' Collaborating Investigators to Present Data at the American Society of Hematology Annual Meeting 2014
November 6, 2014Atara Biotherapeutics' collaborators at Memorial Sloan Kettering Cancer Center will present data on ongoing clinical studies with cytomegavirus T cell therapy at the Annual Meeting of the American Society of Hematology 2014 Dec 6-9 in San Francisco.
More »
Otonomy obtains rights to gacyclidine data from Ipsen to support development of OTO-311 as a treatment for tinnitus
November 6, 2014Otonomy enters an exclusive licensing agreement enabling them to utilize Ipsen's gacyclidine data to support worldwide development and registration of OTO-311 for the treatment of tinnitus.
More »